's been running a blood pharming program for quite awhile now, but it's gotten a real kick start this week with the announcement of a partnership with Cleveland-based biotech company Arteriocyte. Arteriocyte, it seems, has developed a Nanofiber Based System, or NANEX, a technology that enables the production of red blood cells without a donor. The two companies hope research will eventually lead to an "in theatre" blood-making machine for the military. So, if there's no donor, where do the progenitor cells come from? Well, that's a little hazy at this point, though Arteriocyte developed the NANEX using "blood of the umbilical cord" (stem cells), but we don't know what will fuel the final product. Personally, we hope they can squeak out a way to do it using the less controversial "blood of the dragon."